Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$157.85 - $183.09 $4.65 Million - $5.4 Million
-29,469 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$89.33 - $163.65 $2.63 Million - $4.82 Million
29,469 New
29,469 $4.69 Million
Q3 2018

Nov 14, 2018

SELL
$138.11 - $169.04 $429,522 - $525,714
-3,110 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$140.36 - $175.76 $4.5 Million - $5.64 Million
-32,068 Reduced 91.16%
3,110 $487,000
Q1 2018

May 15, 2018

SELL
$152.15 - $192.33 $5.31 Million - $6.71 Million
-34,913 Reduced 49.81%
35,178 $5.67 Million
Q4 2017

Feb 14, 2018

BUY
$60.72 - $167.34 $4.26 Million - $11.7 Million
70,091
70,091 $11.5 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $284M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Element Capital Management LLC Portfolio

Follow Element Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.